EXHIBIT B

Case: 1:12-cv-00772 Document #: 46-3 Filed: 04/20/12 Page 1 of 9 PageID #:487
Page 1of2

LIFO Losses in Biosante Pharmaceuticals, Inc. (BPAX)

Class Period: 02/12/2010 thru 12/15/2011

Movant: Michael O. Bopst

Hold price* $0.6749

Transaction Date Units Price Cost Transaction Date Units Price Proceeds

 - - - -

Purchase 11/21/2011 2000 2.26 $4,520.00 Sale 12/15/2011 (9000.00) 0.49 (4410.00)

Purchase 11/21/2011 3000 2.26 $6,780.00 Sale 12/15/2011 (46000.00) 0.49 (22540.00)

Purchase 9/22/2011 1000 2.44 $2,440.00 Sale 8/19/2011 (4000.00) 2.24 (8960.00)

Purchase 9/22/2011 4000 2.44 $9,760.00 Sale 7/11/2011 (6000.00) 3.38 (20280.00)

Purchase 9/6/2011 2000 2.44 $4,880.00 Sale 7/11/2011 (29000.00) 3.38 (98020.00)

Purchase 9/6/2011 2000 2.44 $4,880.00 Sale 6/10/2011 (6000.00) 2.68 (16080.00)

Purchase 8/10/2011 10000 2.16 $21,600.00 Sale 6/10/2011 (10000.00) 2.68 (26800.00)

Purchase 8/5/2011 10000 2.38 $23,800.00 Sale 4/7/2011 (8000.00) 2.05 (16400.00)

Purchase 7/28/2011 3000 2.97 $8,910.00 Sale 4/7/2011 (32000.00) 2.02 (64640.00)

Purchase 7/28/2011 5000 2.98 $14,900.00 Sale 3/3/2011 (10000.00) 2.27 (22700.00)

Purchase 7/18/2011 1000 3.49 $3,490.00 Sale 2/10/2011 (3000.00) 2.19 (6570.00)

Purchase 7/18/2011 2000 3.49 $6,980.00 Sale 2/10/2011 (4000.00) 2.19 (8760.00)

Purchase 7/12/2011 4000 3.69 $14,760.00

Purchase 7/12/2011 4000 3.69 $14,760.00

Purchase 6/20/2011 6000 2.49 $14,940.00

Purchase 6/20/2011 4000 2.49 $9,960.00

Purchase 6/9/2011 5000 2.81 $14,050.00

Purchase 5/9/2011 1000 2.29 $2,290.00

Purchase 5/6/2011 10000 2.35 $23,500.00

Purchase 4/28/2011 5000 2.34 $11,700.00

Purchase 4/13/2011 5000 2.02 $10,100.00

Purchase 4/11/2011 5000 2.05 $10,250.00

Purchase 4/11/2011 10000 2.03 $20,300.00

Purchase 3/16/2011 2000 1.769 $3,538.00

Purchase 3/16/2011 2000 1.769 $3,538.00

Purchase 3/10/2011 2000 1.94 $3,880.00

Purchase 3/10/2011 4000 1.91 $7,640.00

Purchase Transactions Sales Transactions

Case: 1:12-cv-00772 Document #: 46-3 Filed: 04/20/12 Page 2 of 9 PageID #:488
Page 2of2

LIFO Losses in Biosante Pharmaceuticals, Inc. (BPAX)

Class Period: 02/12/2010 thru 12/15/2011

Movant: Michael O. Bopst

Hold price* $0.6749

Transaction Date Units Price Cost Transaction Date Units Price Proceeds

Purchase Transactions Sales Transactions

Purchase 3/4/2011 4000 1.94 $7,760.00

Purchase 3/4/2011 6000 1.94 $11,640.00

Purchase 3/2/2011 7000 2.06 $14,420.00

Purchase 2/24/2011 3000 2.08 $6,240.00

Purchase 2/24/2011 3000 2.07 $6,210.00

Purchase 2/15/2011 3000 2.07 $6,210.00

Purchase 2/15/2011 5000 2.07 $10,350.00

Purchase 2/14/2011 4000 2.5 $10,000.00

Purchase 2/14/2011 5000 2.5 $12,500.00

Purchase 2/9/2011 3000 2.31 $6,930.00

Purchase 2/9/2011 4000 2.31 $9,240.00

Retained (6,000) 0.6749 (4,049.40)

 161,000 $379,646.00 (173,000) $ (320,209.40)

Total Loss ($59,436.60)

*Shares held as of the date of this filing are valued using the $0.6749 average price of per share between 12/16/11 and 04/11/12.

**The value of common stock still held has been calculated using the purchase price of common stock held minus the average price of 

CHTP common stock between 12/16/11 and 04/11/12 or $0.6749 multiplied by the number of shares held.

Case: 1:12-cv-00772 Document #: 46-3 Filed: 04/20/12 Page 3 of 9 PageID #:489
LIFO Losses in Biosante Pharmaceuticals, Inc. (BPAX)

Class Period: 02/12/2010 thru 12/15/2011

Movant: Guy Jacks

Hold price* $ 0.6749

Transaction Date Units Price Cost Transaction Date Units Price Proceeds

Purchase 12/14/2011 32270 2.51 $80,997.70 Sale 12/5/2011 (2200.00) 2.58 ($5,676.00)

Purchase 7/13/2011 5800 3.72 $21,576.00 Sale 12/2/2011 (1000.00) 2.5701 ($2,570.10)

Purchase 6/27/2011 1000 2.72 $2,720.00 Sale 12/2/2011 (1000.00) 2.54 ($2,540.00)

Purchase 5/27/2011 6000 2.87 $17,220.00 Sale 12/2/2011 (1200.00) 2.55 ($3,060.00)

Purchase 5/17/2011 33000 2.36 $77,880.00 Sale 12/2/2011 (1000.00) 2.53 ($2,530.00)

Purchase 3/3/2011 43095 2.21 $95,239.95 Sale 12/2/2011 (1000.00) 2.5301 ($2,530.10)

Sale 12/2/2011 (2000.00) 2.53 ($5,060.00)

Sale 12/2/2011 (5000.00) 2.5201 ($12,600.50)

Sale 12/2/2011 (5000.00) 2.53 ($12,650.00)

Sale 12/2/2011 (12600.00) 2.53 ($31,878.00)

Sale 12/1/2011 (1000.00) 2.5 ($2,500.00)

Sale 11/28/2011 (1000.00) 2.31 ($2,310.00)

Sale 10/26/2011 (1800.00) 2.57 ($4,626.00)

Sale 7/1/2011 (1000.00) 2.82 ($2,820.00)

Sale 7/1/2011 (5000.00) 2.91 ($14,550.00)

Sale 7/1/2011 (3000.00) 2.9 ($8,700.00)

Sale 6/27/2011 (1000.00) 2.78 ($2,780.00)

Sale 5/12/2011 (43095.00) 2.54 ($109,461.30)

Retained (32270.00) 0.6749 ($21,779.02)

121165 $295,633.65 ($250,621.02)

Total Loss -$45,012.63

Purchase Transactions Sales Transactions

Case: 1:12-cv-00772 Document #: 46-3 Filed: 04/20/12 Page 4 of 9 PageID #:490
*Shares held as of the date of this filing are valued using the $0.6749 average price of per share between 12/16/2011 and 04/11/2012.

**The value of common stock still held has been calculated using the purchase price of common stock held minus the average price of 

CHTP common stock between 12/16/2011 and 04/11/2012 or $0.6749 multiplied by the number of shares held.

Case: 1:12-cv-00772 Document #: 46-3 Filed: 04/20/12 Page 5 of 9 PageID #:491
LIFO Losses in Biosante Pharmaceuticals, Inc. (BPAX)

Class Period: 02/12/2010 thru 12/15/2011

Movant: Patrick Lavoie

Hold price* $ 0.6749

Transaction Date Units Price Cost Transaction Date Units Price Proceeds

Purchase 3/4/2010 15000 1.74 $26,083.50 Sale 12/15/2011 (34200.00) 0.49 ($16,881.12)

Purchase 10/28/2011 900 2.65 $2,385.99 Sale 7/7/2011 (29000.00) 3.13 ($90,758.40)

Purchase 10/25/2011 1300 2.51 $3,260.01 Sale 6/1/2011 (17000.00) 3.15 ($53,539.80)

Purchase 7/18/2011 12000 3.49 $41,924.40 Sale 5/20/2011 (26000.00) 2.57 ($66,885.00)

Purchase 7/13/2011 20000 3.84 $76,796.00 Sale 5/12/2011 (36000.00) 2.41 ($86,785.20)

Purchase 6/8/2011 3000 2.97 $8,919.90 Sale 5/10/2011 (20000.00) 2.43 ($48,590.00)

Purchase 6/3/2011 26000 3.09 $80,350.40 Sale 4/27/2011 (13000.00) 2.31 ($30,019.60)

Purchase 5/27/2011 17000 2.94 $49,990.20 Sale 4/26/2011 (20000.00) 2.26 ($45,190.00)

Purchase 5/16/2011 8000 2.69 $21,506.40 Sale 4/14/2011 (35500.00) 2.01 ($71,344.35)

Purchase 5/13/2011 16000 2.67 $42,729.60 Sale 3/3/2011 (29000.00) 2.34 ($67,865.80)

Purchase 5/10/2011 20000 2.34 $46,874.00 Sale 5/11/2010 (9000.00) 2.33 ($20,968.20)

Purchase 5/4/2011 7500 2.28 $17,109.75 Sale 5/11/2010 (1370.00) 2.34 ($3,203.33)

Purchase 4/28/2011 28500 2.38 $67,838.55 Sale 5/3/2010 (6000.00) 2.45 ($14,689.80)

Purchase 4/18/2011 33000 2.11 $69,639.90 Sale 3/5/2010 (14750.00) 1.78 ($26,244.68)

Purchase 3/15/2011 3500 1.78 $6,239.45 Sale 2/19/2010 (9000.00) 1.83 ($16,460.10)

Purchase 3/4/2011 32000 1.95 $62,409.60

Purchase 12/7/2010 9000 1.46 $13,154.40

Purchase 5/14/2010 20000 2.25 $45,020.00

Purchase 5/4/2010 3700 2.18 $8,075.62

Purchase 4/27/2010 7500 2.17 $16,260.75

Purchase 3/5/2010 2500 1.74 $4,359.75

Purchase 3/4/2010 15000 1.74 $26,083.50

Purchase 2/26/2010 1750 1.59 $2,774.80

Purchase 2/25/2010 7000 1.61 $11,279.80

Purchase Transactions Sales Transactions

Case: 1:12-cv-00772 Document #: 46-3 Filed: 04/20/12 Page 6 of 9 PageID #:492
Purchase 2/22/2010 6000 1.72 $10,330.20

Purchase 2/19/2010 9000 1.66 $14,949.90 Retained (25330.00) 0.6749 ($17,095.22)

325,150 $776,346.37 (325150.00) ($676,520.60)

Total Loss -$99,825.77

*Shares held as of the date of this filing are valued using the $0.6749 average price of per share between 12/16/2011 and 04/11/2012.

**The value of common stock still held has been calculated using the purchase price of common stock held minus the average price of 

CHTP common stock between 12/16/2011 and 04/11/2012 or $0.6749 multiplied by the number of shares held.

Case: 1:12-cv-00772 Document #: 46-3 Filed: 04/20/12 Page 7 of 9 PageID #:493
LIFO Losses in Biosante Pharmaceuticals, Inc. (BPAX)

Class Period: 02/12/2010 thru 12/15/2011

Movant: George Papylion

Hold price* $ 0.6749

Transaction Date Units Price Cost Transaction Date Units Price Proceeds

Purchase 8/10/2011 5000 2.16 $10,800.00

Purchase 8/4/2011 5000 2.2 $11,000.00

Purchase 8/4/2011 5000 2.4 $12,000.00

Purchase 8/4/2011 5000 2.39 $11,950.00

Purchase 7/28/2011 5000 2.99 $14,950.00

Purchase 7/28/2011 5000 2.95 $14,750.00

Retained (30000.00) 0.6749 ($20,247.00)

30,000 $75,450.00 (30000.00) ($20,247.00)

Total Loss ($55,203.00)

*Shares held as of the date of this filing are valued using the $0.6749 average price of per share between 12/16/2011 and 04/11/2012.

**The value of common stock still held has been calculated using the purchase price of common stock held minus the average price of 

CHTP common stock between 12/16/2011 and 04/11/2012 or $0.6749 multiplied by the number of shares held.

Purchase Transactions Sales Transactions

Case: 1:12-cv-00772 Document #: 46-3 Filed: 04/20/12 Page 8 of 9 PageID #:494
LIFO Losses in Biosante Pharmaceuticals, Inc. (BPAX)

Class Period: 02/12/2010 thru 12/15/2011

Movant: Quynh-Ly Pham

Hold price* $ 0.6749

Transaction Date Units Price Cost Transaction Date Units Price Proceeds

Purchase 12/14/2011 30900 2.55 $78,795.00 Sale 12/2/2011 (17291.00) 2.58 ($44,610.78)

Purchase 12/6/2011 4580 2.53 $11,587.40 Sale 12/5/2011 (11129.00) 2.6 ($28,935.40)

Purchase 12/6/2011 24626 2.52 $62,057.52 Sale 12/6/2011 (29206.00) 2.56 ($74,767.36)

Purchase 12/2/2011 25300 2.53 $64,009.00

Purchase 12/1/2011 3120 2.42 $7,550.40

Retained (30900.00) 0.6749 ($20,854.41)

88,526 $223,999.32 (88526.00) ($169,167.95)

Total Loss ($54,831.37)

*Shares held as of the date of this filing are valued using the $0.6749 average price of per share between 12/16/2011 and 04/11/2012.

**The value of common stock still held has been calculated using the purchase price of common stock held minus the average price of 

CHTP common stock between 12/16/2011 and 04/11/2012 or $0.6749 multiplied by the number of shares held.

Purchase Transactions Sales Transactions

Case: 1:12-cv-00772 Document #: 46-3 Filed: 04/20/12 Page 9 of 9 PageID #:495